Hello, Guest!

Federal Civilian

NIST Backs Small Businesses Working on Manufacturing, Drug Development Projects

R&D funding

NIST Backs Small Businesses Working on Manufacturing, Drug Development Projects

The National Institute of Standards and Technology has announced that it will invest almost $3 million in small business research and development projects related to advanced manufacturing, drug development and other priority areas.

NIST said it will grant 10 companies up to $100,000 each in Small Business Innovation Research Phase I funds to establish the feasibility of their R&D proposals. Meanwhile, five companies will each receive up to $400,000 in Phase II funds to continue ongoing efforts, NIST said.

Recipients of the full $100,000 Phase I investment include Durham, North Carolina-based Applied Research Transformation, which proposed to create a commercial system for measuring and controlling bond strength in 3D-printed concrete. Another is San Antonio-based SygnaMap, which aims to support drug development by developing a computational platform for analyzing spatial metabolomics data.

One of the Phase II companies to receive $400,000 is the Alexandria, Virginia-based Criticality Sciences, which is developing measurement techniques to support resilience investments in critical infrastructure organizations.

Businesses that complete Phase I can apply for Phase II funding. Phase III of NIST’s program is expected to focus on technology commercialization.

Sign Up Now! Potomac Officers Club provides you with Daily Updates and News Briefings about Federal Civilian

Category: Federal Civilian

Tags: advanced manufacturing drug development federal civilian National Institute of Standards and Technology Research and Development small business Small Business Innovation Research